Providence tests vaccine against recurrence of breast cancer

It’s been a long-time goal in the fight against cancer: Using the body’s own immune system to fight the disease.

Everett’s Providence Regional Cancer Partnership is one of 13 sites nationally that is testing whether a vaccine, in combination with another medication, is effective in preventing a recurrence in certain types of breast cancer.

They hope to recruit about 50 women to participate in the study. The patients they seek must have low-to-moderate amounts of the HER2 protein present in their cancer.

Currently women with high amounts of HER2 protein are given a drug called Herceptin to try to prevent recurrence. That’s about 25 percent of women diagnosed with breast cancer, said Dr. Jason Lukas, an oncologist at the cancer partnership.

The medical study being conducted in Everett and other sites nationally is to see if this drug, in combination with a vaccine, is effective in preventing a recurrence of breast cancer in women who have low-to-moderate presence of the protein in their tumors.

The vaccine is made in part from the HER2 protein and a drug that stimulates the production of white blood cells.

If the study results show that the combination treatment is effective in preventing breast cancer recurrence, it would be a major step in battling the disease, Lukas said.

The recurrence rate in women who have low-to-moderate amounts of HER2 protein depends on the size of the tumor when they are diagnosed, from a low of 10 percent to as high as 60 percent, he said.

The tests that will be conducted in Everett are the phase 2 trials, or second step tests of the medications. Initial tests involving small groups of women have shown some positive results, dropping the recurrence rate 15 to 20 percent, Lukas said.

“There’s been vaccines tried for other types of solid tumors, but they haven’t yet shown as much potential,” Lukas said. “This is the one where the data seem to be the most compelling.”

The study will document whether women are disease-free 24 months after receiving the treatments.

Some women participating in the study will receive Herception alone. Others will get Herceptin plus the vaccine. Patients will be treated with Herception every three weeks for one year, beginning no later than 12 weeks after completing standard chemotherapy and radiation treatments.

The vaccine treatments will begin with shots every three weeks for a total of six. After that, booster shots are given 12, 18, 24 and 30 months later.

Everett is the only cancer center in Washington participating in the study. Other sites include the M.D. Anderson Cancer Center in Houston, Texas, and the Katzen Cancer Research Center at George Washington University in Washington, D.C.

Lukas said he and another doctor first began exploring the idea of a vaccine to prevent some types of breast cancer recurrence while he was in the Navy. An Army physician they knew also was working to develop the same idea.

Once all three left the military, they worked to launch a national study of the technique, Lukas said.

Vaccines work with the immune system to fight disease. People get cancer because the body’s immune system, for whatever reason, fails to attack it.

The hope is that the vaccine will help Herceptin to work even more effectively, said Marilyn Birchman, clinical research manager at Providence Regional Cancer Partnership.

“It would be nice to have a therapy that’s targeting the breast cancer, with so many less dire effects,” she said. “It’s targeting that cancer cell essentially, and much less toxic than chemotherapy.”

Sharon Salyer: 425-339-3486; salyer@heraldnet.com.

More in Local News

Suspect sought in two Everett bank robberies

He’s described as 5-foot-10 to 6-foot-1, with dark hair and a goatee, and may have a neck tattoo.

Jogger unharmed after fending off attacker in Edmonds

Police released video of a man they believe to be the attacker.

Two missing men found, one alive and one dead

The man found alive was found in an apartment across the hallway and taken to a hospital.

Darrington School Board dealing with upheavals

The crux of the controversy seems to be the superintendent’s job.

Alaska Airlines has selected destinations for new service from Paine Field. (Alaska Airlines)
Alaska Airlines will fly from Everett to 8 West Coast cities

Two destinations that didn’t make the list were Spokane and Hawaii.

Three teens arrested for Marysville school vandalism

Windows were broken and a trash bin was on fire Sunday night at a Marysville middle school.

Langley mayor threatens newspaper with lawsuit

The mayor threatened to sue the paper over claims he withheld public records disclosure information.

Divers called to recover body after train hits pedestrian

The accident was reported by a BNSF crew near Woods Creek in Monroe.

Katharine Graham, then CEO and chairwoman of the board of The Washington Post Co., looks over a copy of The Daily Herald with Larry Hanson, then The Herald’s publisher, during her visit to Everett on Sept. 20, 1984. The Washington Post Co. owned The Herald from 1978 until 2013. (Herald archives)
A local connection to history

Retired Herald publisher Larry Hanson remembers The Post’s Katharine Graham, who visited several times.

Most Read